BRAF and melanoma: Overall, the alterations in major components of the MAPK, such as BRAF and NRAS mutations, and mTOR pathways, PTEN loss and AKT overexpression, seem to have substantial influence in melanoma progression, being both pathways linked to survival and chemoresistence in melanoma [3,171,172].